Navigation Links
Confronting Influenza: Are We Prepared?

"Confronting Influenza: Are We Prepared?" A Symposium Presented by The Howard Hughes Medical Institute and The Center for Strategic and International Studies.

The Howard Hughes Medical Institute (HHMI) and the Center for Strategic and International Studies (CSIS) cordially invite you to attend a symposium on the current state of research, development of prophylactic and therapeutic treatments, and U.S. and global strategies aiming to manage both annual and possible global pandemic influenza outbreaks.

World-renowned speakers will include:

  • Stephen C. Harrison, HHMI Investigator and Professor of Biological Chemistry and Molecular Pharmacology, Professor of Pediatrics and Director of the Harvard-Armenise Center for Structural Biology at Harvard Medical School; and Head of the Laboratory of Molecular Medicine at Children's Hospital, Boston;
  • Dominick A. Iacuzio, Medical Director at Hoffman-La Roche, Inc;
  • Robert A. Lamb, HHMI Investigator and John Evans Professor of Molecular and Cellular Biology at Northwestern University, Evanston, and Professor of Microbiology-Immunology at Northwestern University Medical School;
  • Peter Palese, Chairman and Professor, Department of Microbiology, Mt. Sinai School of Medicine;
  • Timothy M. Uyeki, Medical Epidemiologist, Influenza Branch, Division of Viral and Rickettsial Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention; and
  • Robert G. Webster, Rose Marie Thomas Chair, Division of Virology, St. Jude Children's Research Hospital; Consultant to the World Health Organization (WHO) and the National Institute of Allergy and Infectious Diseases (NIAID); and Director of the U.S. Collaborating Center of the WHO dealing with the ecology of animal influenza viruses.

    Discussion topics will include the structure of the influenza viral proteins and the relevance of that structure for drug development, lessons learned from the 1918 pandemic, current H5N1 (Avia n influenza) developments in Asia, the state of U.S. preparedness and influenza surveillance, and the private sector's views on drug development.


  • Source:Howard Hughes Medical Institute

    Related biology news :

    1. RNA project to create language for scientists worldwide
    2. Disease diagnosis, biodefense among UH chemical research projects
    3. New project aims to make large-scale lobster farms feasible
    4. New Scripps Oceanography project to study sediments and ecosystem restoration in Venice lagoon
    5. ‘Blue Brain?project explores thought at molecular level
    6. Grand Challenges in Global Health initiative funds Yale project
    7. Virtual microscopy project wins educational technology award
    8. St. Jude projects 90 percent cure rate for ALL
    9. UCLA study of community health project shows how group dynamics affect fitness, eating habits
    10. Large-scale genomics project will hunt genes behind common childhood diseases
    11. Ground spider diversity studied in research project
    Post Your Comments:

    (Date:10/29/2015)... Oct. 29, 2015  The J. Craig Venter Institute ... "DNA Synthesis and Biosecurity: Lessons Learned and Options for ... Health and Human Services guidance for synthetic biology providers ... --> --> Synthetic ... the potential to pose unique biosecurity threats. It now ...
    (Date:10/29/2015)... health pioneer, Joseph C. Kvedar , MD, describes ... wellness, and the business opportunities that arise from it ... Healthy Things . Long before health and wellness ... vice president, Connected Health, Partners HealthCare, was creating a ... the hospital or doctor,s office into the day-to-day lives ...
    (Date:10/27/2015)... -- In the present market scenario, security is one ... verticals such as banking, healthcare, defense, electronic gadgets, and ... secure & simplified access control and growing rate of ... bank accounts, misuse of users, , and so on. ... and smartphones are expected to provide potential opportunities for ...
    Breaking Biology News(10 mins):
    (Date:11/25/2015)... , Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. ... its business and prospects remain fundamentally strong and ... (zoptarelin doxorubicin) recently received DSMB recommendation to continue ... following review of the final interim efficacy and ... Primary Endpoint in men with heavily pretreated castration- ...
    (Date:11/25/2015)... ... November 25, 2015 , ... Jessica Richman and Zachary Apte, ... their initial angel funding process. Now, they are paying it forward to other ... stage investments in the microbiome space. In this, they join other successful ...
    (Date:11/24/2015)... SAN DIEGO , Nov. 24, 2015 Halozyme Therapeutics, ... Jaffray Healthcare Conference in New York on ... Dr. Helen Torley , president and CEO, will provide a ... New York at 1:00 p.m. ET/10:00 a.m. ... communication and investor relations, will provide a corporate overview. --> ...
    (Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
    Breaking Biology Technology: